Lund University Publications
metadata only
Improved outcome after relapse in children with acute myeloid leukaemia
In the Nordic Society for Paediatric Haematology and Oncology paediatric study acute myeloid leukaemia (AML) 93, event-free survival was 50% and overall survival was 66%, indicating that many patients were cured following relapse. Factors influencing outcome in children with relapsed AML were invest
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clove In The Treatment Of Relapsed Or Resistant Acute Leukemia In Children#1087185
- Quality of Life Study for Adult Patients With Acute Lymphoblastic Leukemia#1074174
- Extension Study With Tosedostat in Relapsed/Refractory Acute Myeloid Leukemia#906220
- Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL)#1094493
- Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies#812791
Record · ID 1166741
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive